John Wright, MD
Orthopaedic Surgery · Kearney, NENPI 1992745913
Payments from drug & device makers
Across 230 payments — averaging $5143.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kaleo, Inc.$904K
- Stryker$278K
- Musculoskeletal Transplant Foundation Inc.$246
- Integra Lifesciences Corporation$244
- Medical Device Business Services, Inc.$109
- Johnson & Johnson$97
- plus $285 from 9 others
What the payments were for
- Consulting fees$228,93819%
- Travel & lodging$46,3734%
- Food & beverage$3,0930%
- Ownership interest$189,20816%
- Other$715,39760%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kaleo, Inc. | 6 | $904,362 |
| Stryker | 203 | $277,667 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $246 |
| Integra Lifesciences Corporation | 1 | $244 |
| Medical Device Business Services, Inc. | 2 | $109 |
| Johnson & Johnson | 4 | $97 |
| Zimmer Biomet | 1 | $48 |
| EMD Serono, Inc. | 2 | $47 |
| Amgen | 3 | $47 |
| Linvatec Corporation | 2 | $41 |
| Motive Health, Inc. | 1 | $30 |
| Orthofix Medical, Inc. | 1 | $27 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Organogenesis Inc. | 1 | $15 |
| Si-bone, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,183,009 in reported general payments places this provider in the 95th percentile of 155 orthopaedic surgery providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 25 | $401 |
| Amoxicillin | 188 | $212 |
| Meloxicam | 32 | $93 |
| Clindamycin Hcl | 34 | $72 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Kearney
- Heber CrockettKearney$4.2M
- David HuebnerKearney$131K
- James MahalekKearney$11K
- Dennis McGowanKearney$11K
- Chris WilkinsonKearney$7K
- Patrick HarrisonKearney$6K
- Ryan DeblisKearney$5K
- Todd SekundiakElkhorn$7.3M
- Edward FehringerOmaha$2M
- Joshua UrbanOmaha$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.